We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.33B
AUM Growth
-$60.7M
Cap. Flow
+$29.7M
Cap. Flow %
2.24%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
+$22.9M
2
IMDX
Insight Molecular Diagnostics
IMDX
+$6.83M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 51.82%
2 Consumer Staples 32.54%
3 Industrials 5.34%
4 Technology 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$609M 45.94%
8,592,007
– –
MNST icon
2
Monster Beverage
MNST
$94.3B
$432M 32.54%
9,312,976
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$117M 8.81%
690,000
– –
AXON
4
Axon Enterprise
AXON
$42.5B
$70.8M 5.34%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$55.2M 4.16%
34,935,485
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$21M 1.58%
1,167,685
+300,188
+35% +$6.83M
BTRS
7
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$19.8M 1.49%
+3,977,701
New +$22.9M
SER icon
8
Serina Therapeutics
SER
$30M
$1.73M 0.13%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Broadwood Capital held 8 positions worth $1.33B, down 4.4% from $1.39B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q2 2022 filing shows 1 new and 1 increased positions. Its largest new stake was BTRS Holdings Inc. Class 1 Common Stock: 3,977,701 shares worth $19.8M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 55% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital's largest Q2 2022 buy was BTRS Holdings Inc. Class 1 Common Stock: 3,977,701 shares worth $19.8M.
  • Broadwood Capital added most to Insight Molecular Diagnostics in Q2 2022, an estimated $6.83M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.33B portfolio in Q2 2022.
  • Broadwood Capital opened 1 new position and closed 0 in Q2 2022.
  • Broadwood Capital's portfolio value fell 4.4% quarter-over-quarter to $1.33B.

Based on Broadwood Capital's 13F filing for Q2 2022, filed 15 Aug 2022.